Alzheimer’s patient shares new drug hopes that could treat the causes of the disease

About This Source - Sky News

Sky News is a British free-to-air television news channel and organisation. Sky News is distributed via a radio news service, and through online channels. It is owned by Sky Group, a division of Comcast. John Ryley is the head of Sky News, a role he has held since June 2006.

Recent from Sky News:

  • COVID-19: Businesses fear for delayed ‘Freedom Day’
  • Tory rebel: Impact of foreign aid cut ‘very severe’
  • COVID-19: Lockdown easing delay ‘inevitable’
  • Sky News published this video item, entitled “Alzheimer’s patient shares new drug hopes that could treat the causes of the disease” – below is their description.

    Silvia Speight was diagnosed with Alzheimer’s disease four years ago, and spoke to Sky News her hope for the newest Alzheimer’s trial drug, with her daughter Tanya Ord.

    Aducanumab targets amyloid – plaque that builds up in the brains of people with Alzheimer’s – helping to slow the onset of the condition.

    It is the first treatment to target the cause of the disease, as existing ones only help to ease symptoms.

    Sky News YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    Leave a Comment